Vaccines are biological preparation which help in improving immunity of individuals against particular disease. A vaccine generally contains an agent which resembles a disease causing microbe and is typically produced from killed or weakened form of the microorganism, its surface proteins or its toxins. The agent assists in stimulating the individual’s body’s immune system in order to identify the agent as a foreign object and, destroy and also remember it. The global vaccines market was valued at around US$ 28.0 Bn in 2016 and is expected to post CAGR of over 6.0% from 2017 to 2025 to reach value of around US$ 48.0 Bn by 2025. Rise in incidence of infectious diseases and emergence of new diseases is likely to fuel expansion of the global vaccines market from 2017 to 2025.
Get Report Sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=21
Multivalent segment expected to maintain its dominance in terms of valance
In terms of valance, multivalent segment is projected to hold dominant share of global vaccines market during the forecast period and is likely to expand at CAGR of around 6.2% from 2017 to 2025. Advantages of multivalent vaccines such as complete immunization against a wide range of antigen strains, reduced clinic visits for immunization, and convenience offered to physicians and patients are likely to increase the adoption of multivalent vaccines in the near future.
Injectable vaccines to maintain its lead in terms of market share
In terms of route of administration, injectable vaccines segment are projected to account for the largest share and expected to witness robust growth during the forecast period. Majority of the vaccines available today are administered through the intramuscular route which is the major reason for the large market share of the injectable segment.
Pneumococcal disease indication is expected to be most promising segment to invest in
High prevalence of the pneumococcal disease along with introduction of the pneumococcal conjugate vaccine (PCV) by countries in their immunization programmes is expected to fuel the growth of the market. Polio segment is expected to witness the growth rate of 5.7% during the forecast period due to continued focus of local governments to increase polio vaccination coverage is a major driving factor for the growth of the segment.
Hospital pharmacies is anticipated to account for the major share in terms of distribution channel
By distribution channel, the hospital pharmacies is projected to have the largest share and also record the highest growth rate during the forecast period. Retail pharmacies are expected to have a growth rate of 5.8% during the forecast period due to increasing healthcare spending by consumers and rising disease awareness levels is contributing to the growth of the segment.